The Digital Source For China's Tech Innovation Since 2000

China Tech Buzz

Global News Impacting Chinese Tech

Tencent axes all exclusive label deals in China following antitrust clampdown

September 2, 2021
Source: musicbusinessworldwide.com musicbusinessworldwide.com
News Snapshot:
Tencent Holdings and its majority-owned music arm Tencent Music Entertainment have ended all exclusive deals held with global labels in China. After being hit with an exclusivity ban by China’s State Administration of Market Regulation (SAMR) in July, Tencent published a statement on WeChat on Tuesday (August 31) announcing that as of August 23, it had officially written to all “upstream copyright” holders to end their exclusive agreements. In July, Tencent was fined 500,000 yuan (approx $77,000) by SAMR and given a 30 day-deadline to give up its exclusive deals in China, following an antitrust clampdown in the nation. TME...
GO TO ORIGINAL SOURCE →
China Tech Buzz Topics: Antitrust | ARM | ban | boycott | Business | CEO | China | Chinese | cloud | copyright | currency | entertainment | fine | IT | license | licensing | music | NetEase | QQ | Renminbi | Signal | social media | Tencent | WeChat | Yuan

Other News:

Trump's deal with Saudi sparks fears of Middle East nuclear race

July 22, 2026
indiatoday.in indiatoday.in

Volkswagen’s Chinese branch doubles down on self-driving technology

July 22, 2026
euronews.com euronews.com

Punjab becomes first state to introduce AI as mainstream subject from classes 1

July 22, 2026
tribuneindia.com tribuneindia.com

Home Affairs speeds up digital services and immigration reforms

July 22, 2026
devdiscourse.com devdiscourse.com

Gateway to Opportunities: Where Innovation Serves People — Hangzhou's Journey from Countryside to Robotics Labs

July 22, 2026
manilatimes.net manilatimes.net

Here’s how AI is driving India's data centre investment pipeline

July 22, 2026
businesstoday.in businesstoday.in

Labor to expand Paid Prac for frontline health workers

July 22, 2026
perthnow.com.au perthnow.com.au

Ribo Discloses Positive Data from Vortosiran Phase 2a Trial – World's First Clinical Data on siRNA-Mediated FXI Inhibition Following Multiple Dosing in Patients with Coronary Artery Disease

July 22, 2026
prnewswire.co.uk prnewswire.co.uk

OpenAI autonomous AI agent escaped security test and hacked Hugging Face

July 22, 2026
techstartups.com techstartups.com
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
  • Contact Us
  • About Us
  • Corrections and Disclosure
  • Privacy Policy
  • Terms & Conditions
© 2026 ChinaTechNews.com. A Service of Asia Media Network.